Back to expert viewsListen to Prof Michael Gibson as he explores the association between cholesterol efflux and adverse CV events. He also discusses the potential of cholesterol efflux as a novel therapeutic target to improve outcomes for patients with CV disease.
Prof. C. Michael Gibson
Share
Listen to Dr. Susan Gabriel share her insights on risk factors for recurrent cardiovascular events following myocardial infarction in a large real-world data analysis of 78,000 patients with multivessel disease.
Listen to Dr. C. Michael Gibson and Dr. Serge Korjian discuss expert insights on the recurrent cardiovascular risk in patients with contemporary CV outcomes trials between 2010-2021.
ACC, American College of Cardiology; ACS, acute coronary syndrome; AHA, American Heart Association; AMI, acute myocardial infarction; ApoA-I, apolipoprotein A-I; ASCVD, atherosclerotic cardiovascular disease; CV, cardiovascular; ESC, European Society of Cardiology; HDL, high-density lipoprotein; LDL, low-density lipoprotein
USA-GEN-0051 | August 2023